Tennessee Lawmakers to Discuss Opioid Treatment Legislation

Lawmakers in Tennessee are set to hold a press conference on Tuesday, March 31, 2026, at 7:30 AM in the Press Conference Room on Floor G of the Cordell Hull Building in Nashville. The event will feature State Senator Page Walley and State Representative Bryan Terry, who will discuss legislative efforts aimed at reducing opioid use in the state.

The press conference will focus on Senate Bill 2149, known as the HOPE Treatment Act. This proposed legislation includes a provision for a clinical trial of ibogaine, which would be supervised by the Food and Drug Administration (FDA). The trial aims to explore innovative treatment solutions for individuals struggling with opioid addiction.

Officials have emphasized that this legislation is part of ongoing efforts to address the state’s opioid crisis. The opioid epidemic has significantly impacted communities across Tennessee, prompting lawmakers to seek new approaches to treatment and recovery.

During the press conference, lawmakers will outline the specifics of the HOPE Treatment Act and its potential implications for opioid treatment in Tennessee. The inclusion of FDA-supervised clinical trials demonstrates a commitment to evidence-based strategies in tackling the opioid crisis.

As the event approaches, it is expected to attract attention from various stakeholders, including healthcare professionals, addiction specialists, and community advocates. The discussion will highlight the importance of exploring new treatment options and the role of legislation in facilitating these efforts.

The press conference aims to inform the public about the proposed measures and engage with those affected by the opioid crisis. It will serve as a platform for lawmakers to communicate their commitment to finding effective solutions to this pressing issue.

Further details regarding the outcomes of the press conference and subsequent actions related to the HOPE Treatment Act will be shared following the event.


Source Information

This article is based on information from public agencies, official statements, and verified public sources.

Editorial Note

This article was compiled using publicly available information and reviewed for accuracy prior to publication.

Corrections

If you notice an error in this article, please contact the newsroom at [email protected]. Corrections are published at the bottom of articles when needed.